Hispidulin
Based on 7 publication(s) in Google Scholar
Hispidulin is a natural flavone with a broad spectrum of biological activities. Hispidulin is a Pim-1 inhibitor with an IC50 of 2.71 μM.
For research use only. We do not sell to patients.
- Purity: 99.74%
- CAS No.: 1447-88-7
- Formula: C16H12O6
- Molecular Weight:300.26
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) Hispidulin
More- Acta Pharm Sin B. 2021 Jan;11(1):143-155. [Abstract]
- Food Chem. 2025 Dec 30:497:146992. [Abstract]
- Food Chem. 2025 May 31:489:144992. [Abstract]
- J Transl Med. 2025 Oct 7;23(1):1062. [Abstract]
- Ind Crops Prod. 2025 Dec 11;239:122458.
- Int J Mol Sci. 2022 Sep 7;23(18):10346. [Abstract]
- University of Edinburgh. 2025 May 29.
-
Cell Proliferation/Viability Assay
-
Cell Migration/Invasion Assay
-
WB
-
Flow Cytometry
-
Bio/Physico-chemical Assay
Biological Activity
IC50: 2.71 μM (Pim-1)[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A-431 | ED50 |
1.2 μg/mL
Compound: hispidulin
|
Cytotoxicity against human A431 cells
Cytotoxicity against human A431 cells
|
[PMID: 10579870] |
| BC1 cell line | ED50 |
>20 μg/mL
Compound: hispidulin
|
Cytotoxicity against human BC1 cells
Cytotoxicity against human BC1 cells
|
[PMID: 10579870] |
| BC1 cell line | ED50 |
19 μg/mL
Compound: hispidulin
|
Cytotoxicity against human BC1 cells
Cytotoxicity against human BC1 cells
|
[PMID: 7931367] |
| Col2 | ED50 |
>20 μg/mL
Compound: hispidulin
|
Cytotoxicity against human Col2 cells
Cytotoxicity against human Col2 cells
|
[PMID: 10579870] |
| Col2 | ED50 |
>20 μg/mL
Compound: hispidulin
|
Cytotoxicity against human Col2 cells
Cytotoxicity against human Col2 cells
|
[PMID: 7931367] |
| HEK293 | EC50 |
7.3 μM
Compound: 12
|
Agonist activity at mouse PPARgamma expressed in HEK293 cells co-expressing with Gal4 reporter vector after 24 hrs by dual-luciferase reporter assay
Agonist activity at mouse PPARgamma expressed in HEK293 cells co-expressing with Gal4 reporter vector after 24 hrs by dual-luciferase reporter assay
|
[PMID: 24955889] |
| HT | ED50 |
10.1 μg/mL
Compound: hispidulin
|
Cytotoxicity against human HT cells
Cytotoxicity against human HT cells
|
[PMID: 10579870] |
| HT-1080 | ED50 |
5.2 μg/mL
Compound: hispidulin
|
Cytotoxicity against human HT1080 cells
Cytotoxicity against human HT1080 cells
|
[PMID: 7931367] |
| Huh-7 | CC50 |
>50 μM
Compound: 14
|
Cytotoxicity against human Huh7.5.1 cells by MTT assay
Cytotoxicity against human Huh7.5.1 cells by MTT assay
|
[PMID: 22445328] |
| Huh-7 | EC50 |
36.3 μM
Compound: 14
|
Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
|
[PMID: 22445328] |
| KB | ED50 |
18.8 μg/mL
Compound: hispidulin
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 10579870] |
| KB | ED50 |
22 μg/mL
Compound: NSC-122415
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 469554] |
| KB | ED50 |
5.6 μg/mL
Compound: hispidulin
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 7931367] |
| KB | ED50 |
96 μg/mL
Compound: 6
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
10.1021/np50005a002 |
| KB-V1 | ED50 |
1.3 μg/mL
Compound: hispidulin
|
Cytotoxicity against human multidrug-resistant KB-V1+ cells in presence of vinblastine
Cytotoxicity against human multidrug-resistant KB-V1+ cells in presence of vinblastine
|
[PMID: 10579870] |
| KB-V1 | ED50 |
2.8 μg/mL
Compound: hispidulin
|
Cytotoxicity against human KBV1 cells
Cytotoxicity against human KBV1 cells
|
[PMID: 7931367] |
| KB-V1 | ED50 |
8.7 μg/mL
Compound: hispidulin
|
Cytotoxicity against human multidrug-resistant KBV1 cells in absence of vinblastine
Cytotoxicity against human multidrug-resistant KBV1 cells in absence of vinblastine
|
[PMID: 10579870] |
| LNCaP | ED50 |
7.1 μg/mL
Compound: hispidulin
|
Cytotoxicity against hormone-dependent human LNCaP cells
Cytotoxicity against hormone-dependent human LNCaP cells
|
[PMID: 10579870] |
| Lu1 | ED50 |
>20 μg/mL
Compound: hispidulin
|
Cytotoxicity against human Lu1 cells
Cytotoxicity against human Lu1 cells
|
[PMID: 10579870] |
| Lu1 | ED50 |
17.6 μg/mL
Compound: hispidulin
|
Cytotoxicity against human Lu1 cells
Cytotoxicity against human Lu1 cells
|
[PMID: 7931367] |
| MDCK | CC50 |
172.46 μM
Compound: 3
|
Cytotoxicity against MDCK cells by MTT assay
Cytotoxicity against MDCK cells by MTT assay
|
[PMID: 18640042] |
| MOLM-13 | IC50 |
6.4 μM
Compound: NSC122415
|
Cytotoxicity against human MOLM-13 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human MOLM-13 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 33026809] |
| MOLM-13 | IC50 |
7 μM
Compound: 40
|
Cytotoxicity against human MOLM-13 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
Cytotoxicity against human MOLM-13 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
|
[PMID: 33393294] |
| MV4-11 | IC50 |
6.8 μM
Compound: 40
|
Cytotoxicity against human MV4-11 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
Cytotoxicity against human MV4-11 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
|
[PMID: 33393294] |
| MV4-11 | IC50 |
8.2 μM
Compound: NSC122415
|
Cytotoxicity against human MV4-11 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human MV4-11 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 33026809] |
| P388 | ED50 |
0.8 μg/mL
Compound: hispidulin
|
Cytotoxicity against mouse P388 cells
Cytotoxicity against mouse P388 cells
|
[PMID: 7931367] |
| SK-MEL-2 | ED50 |
11.5 μg/mL
Compound: hispidulin
|
Cytotoxicity against human SK-MEL-2 cells
Cytotoxicity against human SK-MEL-2 cells
|
[PMID: 7931367] |
| U-373MG ATCC | ED50 |
8.8 μg/mL
Compound: hispidulin
|
Cytotoxicity against human U373 cells
Cytotoxicity against human U373 cells
|
[PMID: 10579870] |
| ZR-75-1 | ED50 |
1.2 μg/mL
Compound: hispidulin
|
Cytotoxicity against hormone-dependent human ZR751 cells
Cytotoxicity against hormone-dependent human ZR751 cells
|
[PMID: 10579870] |
Hispidulin induces cell death in a dose- and time-dependent manner in HepG2 cells. Hispidulin induces apoptosis through mitochondrial dysfunction, which is characterized by decreased Bcl-2/Bax ratio, disrupted mitochondrial membrane potential and increased release of cytochrome C and activated capase-3[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Hispidulin treatment effectively prevents ovariectomy-induced body weight loss and attenuates ovariectomy-induced bone loss. Hispidulin treatment also decreases trabecular spacing in ovariectomy mice[3].
Intraperitoneally administering hispidulin(10 or 50mg/ kg) to rats 30 min before intraperitoneally injecting kainic acid (15mg/kg) increases seizure latency and decreases seizure score. In addition, hispidulin substantially attenuates kainic acid-induced hippocampal neuronal cell death, and this protective effect is accompanied by the suppression of microglial activation and the production of proinflammatory cytokines such as interleukin-1β, interleukin-6, and tumor necrosis factor-α in the hippocampus[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1447-88-7
-
Appearance Solid
-
Molecular Weight 300.26
-
Formula C16H12O6
-
Color Light yellow to yellow
-
SMILES
O=C1C=C(C2=CC=C(O)C=C2)OC3=CC(O)=C(OC)C(O)=C13
-
Synonyms
Dinatin
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (7)
-
Journal Impact Factor
-
Most Recent
-
Acta Pharm Sin B
Chrysin serves as a novel inhibitor of DGK α/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC). [Abstract]2021 Jan;11(1):143-155. PMID: 33532186 -
Food Chem
Effects of sun drying combined with baking processes on the flavor quality of Chongqing Tuocha raw tea. [Abstract]2025 Dec 30:497:146992. PMID: 41285060 -
Food Chem
Flavonoid-mediated metabolic underpinning quality variation in red bud-sport pear mutants. [Abstract]2025 May 31:489:144992. PMID: 40466530 -
J Transl Med
Hispidulin suppresses osteosarcoma by directly targeting FABP4 to disrupt lipid metabolism and inhibit the PI3K/AKT pathway. [Abstract]2025 Oct 7;23(1):1062. PMID: 41057878
Hispidulin purchased from MedChemExpress. Usage Cited in: J Transl Med. 2025 Oct 7;23(1):1062. [Abstract]
Human osteosarcoma MG63 and 143B cells treated with various concentrations (20–60 µM) of HIS (Hispidulin) for 24, 48, and 72 h, as determined by the CCK-8 assay.
Hispidulin purchased from MedChemExpress. Usage Cited in: J Transl Med. 2025 Oct 7;23(1):1062. [Abstract]
The effects of HIS (Hispidulin) (7.5-30 µM) on the migration and invasion abilities of MG63 and 143B cells were examined by Transwell assays.
Hispidulin purchased from MedChemExpress. Usage Cited in: J Transl Med. 2025 Oct 7;23(1):1062. [Abstract]
Hispidulin (HIS) (7.5-15 µM; 48 h). Western blot analysis of the expression levels of G2/M phase-related proteins (CDK1, Cyclin B1), apoptosis-related protein (Bcl-2), and epithelial-mesenchymal transition (EMT)-related proteins (E-cadherin, N-cadherin, Vimentin) in MG63 and 143B cells. β-actin served as a loading control.
Hispidulin purchased from MedChemExpress. Usage Cited in: J Transl Med. 2025 Oct 7;23(1):1062. [Abstract]
Apoptosis in MG63 and 143B cells after HIS (Hispidulin) (7.5-30 µM; 48 h) treatment was detected by Annexin V-FITC/PI double staining followed by flow cytometry.
Hispidulin purchased from MedChemExpress. Usage Cited in: J Transl Med. 2025 Oct 7;23(1):1062. [Abstract]
Changes in intracellular free fatty acid (FFA) concentration and fatty acid synthase (FASN) activity in MG63 and 143B cells after HIS (Hispidulin) (15 µM; 48 h) treatment.
-
-
Int J Mol Sci
Hesperetin from Root Extract of Clerodendrum petasites S. Moore Inhibits SARS-CoV-2 Spike Protein S1 Subunit-Induced NLRP3 Inflammasome in A549 Lung Cells via Modulation of the Akt/MAPK/AP-1 Pathway. [Abstract]2022 Sep 7;23(18):10346. PMID: 36142258 -
Solvent & Solubility
DMSO : 62.5 mg/mL (208.15 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.08 mg/mL (6.93 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.08 mg/mL (6.93 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 50% PEG300 50% Saline
Solubility: 10 mg/mL (33.30 mM); Suspended solution; Need ultrasonic
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocol
HepG2 cells are treated with different concentrations of hispidulin (50, 100, 200 μM) for 24, 48 and 72 h. Following treatment, cells are further incubated with MTT reagents at 37°C for 4 h before DMSO is added, to dissolve farmazan crystals, and absorbance is measured at 570 nm in a microplate reader[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Mice: Tumor are established in mice. Mice are treated with DMSO or Hispidulin at a dosage of 10, 20 or 40 mg/kg/day for 35 days. The body weight of tumour-bearing mice is recorded every week and tumour volume is calculated [2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Purity & Documentation
-
Data Sheet (279 KB)
-
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Korean - KR (396 KB)
- Portuguese - PT (396 KB)
-
Handling Instructions (2659 KB)
References
[1]. Chao SW, et al. Total Synthesis of Hispidulin and the Structural Basis for Its Inhibition of Proto-oncogene KinasePim-1. J Nat Prod. 2015 Aug 28;78(8):1969-76. [Content Brief]
[2]. Gao H, et al. Hispidulin induces apoptosis through mitochondrial dysfunction and inhibition of P13k/Akt signalling pathway in HepG2 cancer cells. Cell Biochem Biophys. 2014 May;69(1):27-34. [Content Brief]
[3]. Zhou R, et al. Hispidulin exerts anti-osteoporotic activity in ovariectomized mice via activating AMPK signaling pathway. Cell Biochem Biophys. 2014 Jun;69(2):311-7. [Content Brief]
[4]. Lin TY, et al. Protective effect of hispidulin on kainic acid-induced seizures and neurotoxicity in rats. Eur J Pharmacol. 2015 May 15;755:6-15. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.3304 mL | 16.6522 mL | 33.3045 mL | 83.2612 mL |
| 5 mM | 0.6661 mL | 3.3304 mL | 6.6609 mL | 16.6522 mL | |
| 10 mM | 0.3330 mL | 1.6652 mL | 3.3304 mL | 8.3261 mL | |
| 15 mM | 0.2220 mL | 1.1101 mL | 2.2203 mL | 5.5507 mL | |
| 20 mM | 0.1665 mL | 0.8326 mL | 1.6652 mL | 4.1631 mL | |
| 25 mM | 0.1332 mL | 0.6661 mL | 1.3322 mL | 3.3304 mL | |
| 30 mM | 0.1110 mL | 0.5551 mL | 1.1101 mL | 2.7754 mL | |
| 40 mM | 0.0833 mL | 0.4163 mL | 0.8326 mL | 2.0815 mL | |
| 50 mM | 0.0666 mL | 0.3330 mL | 0.6661 mL | 1.6652 mL | |
| 60 mM | 0.0555 mL | 0.2775 mL | 0.5551 mL | 1.3877 mL | |
| 80 mM | 0.0416 mL | 0.2082 mL | 0.4163 mL | 1.0408 mL | |
| 100 mM | 0.0333 mL | 0.1665 mL | 0.3330 mL | 0.8326 mL |